Cadence Biomedical Inc, a medical device company focused on neurological injury and neurodegenerative condition rehabilitation, reports it has entered into an agreement with LM Co Ltd to be the exclusive distributor for the Kickstart Walking System in the Republic of Korea, marking its international expansion. Kickstart is a neurorehabilitation system designed to retrain walking following a stroke, incomplete spinal cord injury, and other neurological conditions. The system is engineered to provide walking assistance without electronics.
According to a Cadence Biomedical news release, two versions of Kickstart are available: KickstartPT, an adjustable clinical model ideal for use during therapy sessions, and KickstartPersonal, which is appropriate for use in home and community settings for daily activities.
Two papers presented at the Combined Sections Meeting (CSM) of the American Physical Therapy Association (APTA) in February confirmed the potential of the Kickstart system as both a walking aid and a therapeutic tool, as indicated on the Cadence Biomedical news release.
Terry Han, director of marketing and new business development for LM, says, “Stroke is a large and growing problem in the Republic of Korea. We are thankful for the opportunity to distribute Kickstart and look forward to improving the lives of potentially hundreds of thousands of Koreans.”
Brian Glaister, president and CEO of Cadence Biomedical, says, “Every day I am more and more impressed by Kickstart’s ability to transform the lives of people struggling to walk again. Our partnership with LM is our first in Asia and is an important step in fulfilling our mission of making Kickstart the standard of care for neurorehabilitation across the globe.”
[Source: Cadence Biomedical Inc]